Guest guest Posted September 20, 2004 Report Share Posted September 20, 2004 An excerpt from: Merck Best Practice of Medicine " Glucocorticoid Therapy and Withdrawal " : Glucocorticoid Withdrawal Glucocorticoid withdrawal can present with symptoms of chronic glucocorticoid deficiency or as an acute adrenal crisis [22]. Thus, patients may suffer from anorexia, myalgia, nausea, emesis, lethargy, headache, fever, skin desquamation, arthralgias, weight loss, and postural hypotension. In addition, they may experience exacerbation of previously present autoimmune disease (eg, rheumatoid arthritis, atopic dermatitis, or asthma) or have new autoimmune disease (eg, Hashimoto's thyroiditis or Graves disease). The occurrence of the subjective component of the steroid withdrawal syndrome does not depend on the absence of cortisol from the circulation or an impairment of the hypothalamic-pituitary-adrenal axis, because many of these symptoms may occur while on proper glucocorticoid replacement or while the patient has a normal cortisol response to Cortrosyn (Organon, Inc.). In this instance, the steroid withdrawal syndrome may be a result of difficulties in withdrawing from the high levels of glucocorticoids - a phenomenon that appears to be idiosyncratic [24]. Termination of chronic daily glucocorticoid therapy (longer than 2 weeks) should be gradual - both to prevent development of adrenal insufficiency and to avoid reactivation of the disease under therapy (Table 6). The likelihood of the latter depends on the activity and natural history of the disorder. When there is any chance that the underlying illness may recur, the glucocorticoids should be withdrawn slowly over a period of weeks to months with frequent reassessment of the patients condition. Daily hydrocortisone replacement or double or triple replacement of intermediate-acting glucocorticoids given on alternate days are acceptable methods for weaning patients from glucocorticoid therapy. Adrenal Suppression Recovery of the hypothalamic-pituitary-adrenal axis can take 12 months or longer [9]. Abrupt cessation of glucocorticoid treatment or quick tapering can precipitate an acute adrenal insufficiency crisis. The main symptoms range from anorexia, fatigue, nausea, vomiting, dyspnea, fever, arthralgia, myalgia, and orthostatic hypotension to dizziness, fainting, and circulatory collapse. Hypoglycemia is occasionally observed in children and very thin adult individuals. The diagnosis is a medical emergency, and treatment should be immediate administration of fluids, electrolytes, glucose, and parenteral glucocorticoids. To evaluate adequacy of hypothalamic-pituitary-adrenal axis recovery the rapid Cortrosyn (Organon, Inc.) test should be used. An intravenous bolus of 250 g of corticotropin 124 (Cortrosyn [Organon, Inc.]) is administered and cortisol is measured after 30 or 60 minutes or both. Plasma cortisol concentration of greater than 18 or 20 g/dL, at these times indicates adequate recovery of the hypothalamic-pituitary-adrenal axis [4,19]. http://merck.micromedex.com/bpm/bpmviewall.asp?page=CPM02EN313 I'll tell you where to go! Mayo Clinic in Rochester http://www.mayoclinic.org/rochester s Hopkins Medicine http://www.hopkinsmedicine.org Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.